The inhaler Teva Pharmaceuticals Ltd. will start distributing in Israel to treat pain with cannabis next year may get tested for other plants, including the opium poppy, by developer Syqe Medical.

Syqe, which manufactures the device, will try loading it with opium and other painkilling substances as well as consider selling it in its current cannabis-dispensing form — the one Teva agreed to market — beyond Israel, according to the Tel Aviv-based company’s founder.

Read more on Bloomberg here.